BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3710688)

  • 1. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
    Meryn S; Stein D; Straus EW
    Int J Obes; 1986; 10(1):37-42. PubMed ID: 3710688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Lauritsen KB; Holst JJ; Stadil F; Andersen B
    Digestion; 1983; 26(3):137-45. PubMed ID: 6343164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
    Holst JJ; Schwartz TW; Lovgreen NA; Pedersen O; Beck-Nielsen H
    Int J Obes; 1983; 7(6):529-38. PubMed ID: 6360922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Holst JJ; Sørensen TI; Andersen AN; Stadil F; Andersen B; Lauritsen KB; Klein HC
    Scand J Gastroenterol; 1979; 14(2):205-7. PubMed ID: 432544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
    Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity.
    Meryn S; Stein D; Straus EW
    Metabolism; 1986 Sep; 35(9):798-802. PubMed ID: 3528741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pirenzepine on meal-stimulated gastrointestinal hormones.
    El-Sabbagh HN; Bloom SR; Adrian TE; Prinz RA; Baron JH; Welbourn RB
    Scand J Gastroenterol Suppl; 1980; 66():57-61. PubMed ID: 6113682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
    Amland PF; Jorde R; Giercksky KE; Burhol PG
    Int J Obes; 1984; 8(2):117-22. PubMed ID: 6373640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavior of plasma enteroglucagon and neurotensin in obese patients subjected to biliopancreatic bypass].
    Gianetta E; Bloom SR; Sarson DL; Civalleri D; Bonalumi U; Griffanti Bartoli F; Friedman D; Pitton L; Binda PL; Degrandi R; Scopinaro N
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1915-21. PubMed ID: 7459102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic and gastrointestinal hormones in chronic pancreatitis.
    Besterman HS; Adrian TE; Bloom SR; Christofides ND; Mallinson CN; Ponti V; Lombardo L; Modigliani R; Guerin S; South M
    Digestion; 1982; 24(3):195-208. PubMed ID: 6754514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult cystic fibrosis: postprandial response of gut regulatory peptides.
    Allen JM; Penketh AR; Adrian TE; Lee YC; Sarson DL; Hodson ME; Batten JC; Bloom SR
    Gastroenterology; 1983 Dec; 85(6):1379-83. PubMed ID: 6628932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroidism and gastroenteropancreatic hormone levels.
    Strodel WE; Vinik AI; Eckhauser FE; Thompson NW
    Surgery; 1985 Dec; 98(6):1101-6. PubMed ID: 2416070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
    Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
    Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of plasma pancreatic polypeptides and motilin in obese patients subjected to biliopancreatic bypass].
    Civalleri D; Bloom SR; Sarson DL; Gianetta E; Bonalumi U; Friedman D; Pitton L; Brignole E; Binda PL; Degrandi R; Scopinaro N
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1929-35. PubMed ID: 7459103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut hormones in acute diarrhoea.
    Besterman HS; Christofides ND; Welsby PD; Adrian TE; Sarson DL; Bloom SR
    Gut; 1983 Jul; 24(7):665-71. PubMed ID: 6345284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-entero-pancreatic hormones in gestational diabetes: response to a protein rich meal.
    Hornnes PJ; Kühl C; Lauritsen KB
    Horm Metab Res; 1982 Jul; 14(7):335-8. PubMed ID: 7118058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic glucagon and enteroglucagon in the plasma of patients with liver cirrhosis].
    Kasperska-Czyzykowa T
    Pol Arch Med Wewn; 1983; 69(4-5):315-23. PubMed ID: 6356055
    [No Abstract]   [Full Text] [Related]  

  • 18. A qualitative comparison of canine plasma gastroenteropancreatic hormone response to bombesin and the porcine gastrin-releasing peptide (GRP).
    McDonald TJ; Ghatei MA; Bloom SR; Track NS; Radziuk J; Dupre J; Mutt V
    Regul Pept; 1981 Sep; 2(5):293-304. PubMed ID: 7029673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous recording of the gastro-entero-pancreatic hormonal peptide response to food in man.
    Hornnes PJ; Kühl C; Holst JJ; Lauritsen KB; Rehfeld JF; Schwartz TW
    Metabolism; 1980 Aug; 29(8):777-9. PubMed ID: 6995794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity.
    Jorde R; Burhol PG
    Int J Obes; 1984; 8(5):393-7. PubMed ID: 6394520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.